Peter Altman Bio Cardia, Inc. (BCDA) insider trading activity

Peter Altman is President and CEO of BioCardia, Inc.. Currently has a direct ownership of 112,720 shares of BCDA, which is worth approximately $216,422. The most recent transaction as insider was on Feb 13, 2024, when has been sold 108,108 shares (Common Stock) at a price of $0.46 per share, resulting in proceeds of $49,729. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 113K

5.76% 3M change

79.82% 12M change

Total Value Held $216,422

Peter Altman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 13 2024	BUY Open market or private purchase	$49,729 $0.46 p/Share	108,108 Added 16.29%	555,447 Common Stock
Aug 17 2023	BUY Grant, award, or other acquisition	$3,480 $0.87 p/Share	4,000 Added 0.89%	447,339 Common Stock
Aug 14 2023	BUY Grant, award, or other acquisition	$3,960 $0.88 p/Share	4,500 Added 1.0%	443,339 Common Stock
Jun 23 2023	BUY Grant, award, or other acquisition	$15,025 $2.34 p/Share	6,421 Added 1.44%	438,839 Common Stock
May 31 2023	SELL Payment of exercise price or tax liability	$65,173 $1.77 p/Share	36,821 Reduced 7.85%	432,418 Common Stock
May 26 2023	BUY Open market or private purchase	$9,920 $1.6 p/Share	6,200 Added 1.3%	469,239 Common Stock
May 18 2023	BUY Grant, award, or other acquisition	$185,850 $1.7 p/Share	109,324 Added 19.1%	463,039 Common Stock
Dec 16 2022	BUY Grant, award, or other acquisition	$24,998 $1.68 p/Share	14,880 Added 4.1%	347,827 Common Stock
Sep 23 2022	BUY Open market or private purchase	$2,618 $1.87 p/Share	1,400 Added 0.42%	328,447 Common Stock
Sep 22 2022	BUY Open market or private purchase	$5,611 $1.81 p/Share	3,100 Added 0.94%	327,047 Common Stock
Sep 21 2022	BUY Open market or private purchase	$5,280 $1.92 p/Share	2,750 Added 0.84%	323,947 Common Stock
Jun 10 2022	BUY Open market or private purchase	$6,570 $1.46 p/Share	4,500 Added 1.38%	321,197 Common Stock
May 13 2022	BUY Open market or private purchase	$3,723 $1.38 p/Share	2,698 Added 0.77%	348,143 Common Stock
May 12 2022	SELL Payment of exercise price or tax liability	$41,509 $1.32 p/Share	31,446 Reduced 9.03%	316,697 Common Stock
May 12 2022	BUY Open market or private purchase	$13,562 $1.2 p/Share	11,302 Added 3.17%	345,445 Common Stock
May 11 2022	BUY Open market or private purchase	$1,300 $1.3 p/Share	1,000 Added 0.3%	334,143 Common Stock
Apr 29 2022	BUY Open market or private purchase	$4,347 $1.61 p/Share	2,700 Added 0.8%	333,143 Common Stock
Apr 28 2022	BUY Open market or private purchase	$3,657 $1.59 p/Share	2,300 Added 0.69%	330,443 Common Stock
Apr 18 2022	BUY Open market or private purchase	$18,765 $1.39 p/Share	13,500 Added 3.95%	328,143 Common Stock
Apr 14 2022	BUY Grant, award, or other acquisition	-	76,734 Added 19.61%	314,643 Common Stock
Jan 11 2022	BUY Open market or private purchase	$187 $1.87 p/Share	100 Added 0.03%	353,715 Common Stock
Nov 18 2021	BUY Open market or private purchase	$11,000 $2.2 p/Share	5,000 Added 2.06%	237,909 Common Stock
Aug 17 2021	BUY Open market or private purchase	$10,290 $2.94 p/Share	3,500 Added 1.48%	232,909 Common Stock
Jun 10 2021	SELL Payment of exercise price or tax liability	$50,338 $4.35 p/Share	11,572 Reduced 4.8%	229,409 Common Stock
Apr 21 2021	SELL Grant, award, or other acquisition	-	33,581 Reduced 12.23%	240,981 Common Stock

Peter Altman

President and CEO

Sunnyvale, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCDA shares.

Notify only if

Value

Insider Trading

Get notified when an Bio Cardia, Inc. insider buys or sells BCDA shares.

Notify only if

Operation

Value

Type

News

Receive news related to BioCardia, Inc.

Track Activities on BCDA

Account